9490 NEOGENOMICS WAY, FORT MYERS, FL
Announces Executive Leadership and Board of Directors Succession Plan
Alicia Olivo Departs as General Counsel of NeoGenomics, Effective September 21
Financial Results, Press Release
Amended material disclosure
Announces Settlement of Voluntary Disclosure to OIG-HHS
Appoints Carolyn Starrett to its Board of Directors
NeoGenomics Completes $316.25 Million Convertible Notes Offering
Announces Pricing of Offering of $275 Million Convertible Senior Notes
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Prospectus filed pursuant to Rule 424(b)(7)